Cancer, Viruses, and Mass Migration: Paul Berg's Venture into Eukaryotic Biology and the Advent of Recombinant DNA Research and Technology, 1967-1980 [Book Review]

Journal of the History of Biology 41 (4):589 - 636 (2008)
Abstract
The existing literature on the development of recombinant DNA technology and genetic engineering tends to focus on Stanley Cohen and Herbert Boyer's recombinant DNA cloning technology and its commercialization starting in the mid-1970s. Historians of science, however, have pointedly noted that experimental procedures for making recombinant DNA molecules were initially developed by Stanford biochemist Paul Berg and his colleagues, Peter Lobban and A. Dale Kaiser in the early 1970s. This paper, recognizing the uneasy disjuncture between scientific authorship and legal invention in the history of recombinant DNA technology, investigates the development of recombinant DNA technology in its full scientific context. I do so by focusing on Stanford biochemist Berg's research on the genetic regulation of higher organisms. As I hope to demonstrate, Berg's new venture reflected a mass migration of biomedical researchers as they shifted from studying prokaryotic organisms like bacteria to studying eukaryotic organisms like mammalian and human cells. It was out of this boundary crossing from prokaryotic to eukaryotic systems through virus model systems that recombinant DNA technology and other significant new research techniques and agendas emerged. Indeed, in their attempt to reconstitute 'life' as a research technology, Stanford biochemists' recombinant DNA research recast genes as a sequence that could be rewritten thorough biochemical operations. The last part of this paper shifts focus from recombinant DNA technology's academic origins to its transformation into a genetic engineering technology by examining the wide range of experimental hybridizations which occurred as techniques and knowledge circulated between Stanford biochemists and the Bay Area's experimentalists. Situating their interchange in a dense research network based at Stanford's biochemistry department, this paper helps to revise the canonized history of genetic engineering's origins that emerged during the patenting of Cohen-Boyer's recombinant DNA cloning procedures.
Keywords Paul Berg  recombinant DNA technology  genetic engineering  cancer research  lysogeny  eukaryotic biology  Nixon’s war on cancer  biotechnology
Categories (categorize this paper)
DOI 10.1007/s10739-008-9149-9
Options
 Save to my reading list
Follow the author(s)
Edit this record
My bibliography
Export citation
Find it on Scholar
Mark as duplicate
Request removal from index
Revision history
Download options
Our Archive


Upload a copy of this paper     Check publisher's policy     Papers currently archived: 30,727
External links

Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
Through your library
References found in this work BETA

View all 28 references / Add more references

Citations of this work BETA
From Genetic to Genomic Regulation: Iterativity in microRNA Research.Maureen A. O'Malley, Kevin C. Elliott & Richard M. Burian - 2010 - Studies in History and Philosophy of Science Part C 41 (4):407-417.
Ludwik Gross, Sarah Stewart, and the 1950s Discoveries of Gross Murine Leukemia Virus and Polyoma Virus.Gregory J. Morgan - 2014 - Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences 48:200-209.

View all 12 citations / Add more citations

Similar books and articles
Taking DNA to Market and Regulatory Default.Michael J. Flower - 1981 - Bioethics Quarterly 3 (2):112-127.
Interactions Among Theory, Experiment, and Technology in Molecular Biology.Kenneth F. Schaffner - 1994 - PSA: Proceedings of the Biennial Meeting of the Philosophy of Science Association 1994:192 - 205.
Local Control of Recombinant DNA Research ? Only for Accidents?Ken Christensen - 1978 - Journal of Law, Medicine & Ethics 6 (2):4-6.
Reporting Recombinant DNA.Nicholas Wade - 2001 - Perspectives in Biology and Medicine 44 (2):192-198.
Leviticus and DNA: A Very Old Look at a Very New Problem.Benjamin Freedman - 1980 - Journal of Religious Ethics 8 (1):105 - 113.
Technology Transfer at Harvard University.Daniel Steiner - 1980 - Bioethics Quarterly 2 (4):203-211.
How Distinctive is Genetic Information?M. Richards - 2001 - Studies in History and Philosophy of Science Part C 32 (4):663-687.
The Recombinant DNA Debate.Stephen P. Stich - 1978 - Philosophy and Public Affairs 7 (3):187-205.
Added to PP index
2011-05-29

Total downloads
13 ( #365,635 of 2,197,331 )

Recent downloads (6 months)
1 ( #299,047 of 2,197,331 )

How can I increase my downloads?

Monthly downloads
My notes
Sign in to use this feature